STOP-BANG Clinical Calculator: Obstructive Sleep Apnea Risk Assessment

The STOP-BANG scoring system is designed to provide immediate clarity regarding your risk of Obstructive Sleep Apnea (OSA). Your final score dictates the clinical urgency of your symptoms. Use this assessment as a foundational diagnostic baseline to share with your primary care physician or sleep specialist.

• Low Risk (0–2): Your physiological markers do not currently indicate a strong likelihood of moderate-to-severe OSA. Monitor symptoms if daytime fatigue persists, and reassess annually or if new symptoms develop such as increased snoring or observed breathing cessation.
• Intermediate Risk (3–4): You exhibit multiple clinical signs of airway obstruction during sleep. Further medical evaluation is highly recommended. Request a consultation with your primary care physician who may refer you for a home sleep apnea test (HSAT) or laboratory polysomnography.
• High Risk (5–8): Critical markers for OSA are present. Immediate consultation for clinical polysomnography (a formal sleep study) is advised to mitigate serious cardiovascular and neurological risks associated with chronic untreated intermittent hypoxia.

Obstructive Sleep Apnea occurs when the muscles in the back of the throat fail to keep the airway open during sleep, leading to repeated cycles of partial or complete upper airway collapse. This produces fragmented sleep architecture and intermittent hypoxia — episodic drops in blood oxygen saturation — that cumulatively damage cardiovascular, metabolic, and neurological function over time.

• Neck Circumference & BMI: Excess adipose tissue surrounding the upper airway exerts continuous circumferential pressure on the trachea and pharynx. When throat muscle tone drops during sleep, this structural compression exponentially increases the risk of luminal collapse. A neck circumference exceeding 40 cm is an independent predictor of OSA, separate from general obesity markers.
• Systemic Hypertension: Repeated nightly oxygen desaturation episodes activate the sympathetic nervous system and renin-angiotensin-aldosterone system. This hormonal cascade forces the cardiovascular system into chronic compensatory overdrive, directly linking untreated OSA to treatment-resistant systemic hypertension and elevated stroke risk.
• Age and Gender Vectors: Pharyngeal tissue elasticity naturally degrades with advancing age, reducing passive airway resistance to collapse. Biological males exhibit a higher predisposition for upper airway collapsibility due to anatomical differences in fat deposition patterns (more pharyngeal fat) and airway geometry compared to biological females.
• Observed Apnea: Witnessed cessation of breathing or gasping during sleep is among the strongest single predictors of clinically significant OSA, representing observable evidence of complete upper airway occlusion rather than partial obstruction.

Underlying Formula: The STOP-BANG aggregate risk is calculated as a simple binary summation:

Total Score = Σ(i=1 to 8) Q_i, where each Q_i ∈ {0, 1}

A value of 1 is assigned for each “Yes” response. The eight criteria are: Snoring loudly (S), Tiredness/daytime fatigue (T), Observed apnea (O), high blood Pressure (P), BMI > 35 kg/m² (B), Age > 50 (A), Neck circumference > 40 cm (N), and Gender = Male (G).

Risk Stratification Thresholds:

• Score 0–2: Low Risk for moderate-to-severe OSA
• Score 3–4: Intermediate Risk — further evaluation recommended
• Score ≥ 5: High Risk — urgent polysomnography referral indicated

Alternative High-Risk Trigger: Per clinical extensions of the model, a STOP sub-score of ≥2 combined with any one of: male gender, BMI > 35, or neck circumference > 40 cm also defaults to High Risk classification, even if the total STOP-BANG score is <5.

Conditional Logic & Edge Cases: To maintain YMYL safety and clinical data integrity, the algorithm enforces a strict all-inputs requirement. Output generation is halted if any of the 8 binary variables are unanswered, preventing falsely low risk scores from incomplete data entry. The live score tracker provides real-time feedback as criteria are completed.

Clinical Validation: Based on the landmark study by Chung et al. (Anesthesiology, 2008), the STOP-BANG questionnaire demonstrates sensitivity of 93.4% for moderate-to-severe OSA (AHI ≥ 15) at a cutoff of ≥3, and sensitivity exceeding 96% for severe OSA (AHI ≥ 30). It is endorsed by the American Society of Anesthesiologists and used as a perioperative screening standard worldwide.

Can I rely on this tool instead of taking a clinical sleep study?
No. The STOP-BANG calculator is a high-sensitivity screening tool, not a diagnostic device. A formal diagnosis of Obstructive Sleep Apnea requires clinical polysomnography — a controlled overnight study that tracks brain waves, blood oxygen levels, heart rate, and respiratory effort. A high STOP-BANG score is a clinical mandate to seek formal evaluation, not a substitute for it.

Why does neck circumference predict sleep apnea risk?
Neck circumference is a highly accurate biomechanical predictor of OSA. A neck size exceeding 40 cm (16 inches) generally indicates an increased concentration of soft tissue and adipose around the pharynx, which significantly raises the probability of airway collapse when throat muscles relax during deep sleep. This relationship between neck circumference and OSA holds even when controlling for overall BMI.

If I score in the high-risk category, what is my next immediate step?
You should export or screenshot your STOP-BANG results and schedule an appointment with a pulmonologist, ENT, or sleep medicine specialist as a priority. They will review your scores alongside your medical history to determine if a continuous positive airway pressure (CPAP) trial, an in-lab polysomnography, or an at-home sleep apnea test (HSAT) is the most appropriate and medically necessary next step.

What is the sensitivity of the STOP-BANG questionnaire?
For moderate-to-severe OSA (AHI ≥ 15), the STOP-BANG demonstrates sensitivity of approximately 93% at a cutoff of ≥3. For severe OSA (AHI ≥ 30), sensitivity exceeds 96%. Its high sensitivity makes it an excellent screening tool, though its specificity is lower, which is why positive screens require confirmatory polysomnography rather than direct clinical action.